389 related articles for article (PubMed ID: 27411305)
1. NOS Expression and NO Function in Glioma and Implications for Patient Therapies.
Tran AN; Boyd NH; Walker K; Hjelmeland AB
Antioxid Redox Signal; 2017 Jun; 26(17):986-999. PubMed ID: 27411305
[TBL] [Abstract][Full Text] [Related]
2. The implications of nitric oxide metabolism in the treatment of glial tumors.
Mazurek M; Rola R
Neurochem Int; 2021 Nov; 150():105172. PubMed ID: 34461111
[TBL] [Abstract][Full Text] [Related]
3. Lipopolysaccharide plus 12-o-tetradecanoylphorbol 13-acetate induction of migration and invasion of glioma cells in vitro and in vivo: Differential inhibitory effects of flavonoids.
Shen SC; Lin CW; Lee HM; Chien LL; Chen YC
Neuroscience; 2006 Jun; 140(2):477-89. PubMed ID: 16580779
[TBL] [Abstract][Full Text] [Related]
4. Nitric oxide and glioma: a target for novel therapy?
Shinoda J; Whittle IR
Br J Neurosurg; 2001 Jun; 15(3):213-20. PubMed ID: 11478055
[TBL] [Abstract][Full Text] [Related]
5. Nitric oxide synthase inhibitors as potential therapeutic agents for gliomas: A systematic review.
Merenzon MA; Hincapie Arias E; Bhatia S; Shah AH; Higgins DMO; Villaverde M; Belgorosky D; Eijan AM
Nitric Oxide; 2023 Sep; 138-139():10-16. PubMed ID: 37279819
[TBL] [Abstract][Full Text] [Related]
6. Adrenomedullin and nitric oxide: implications for the etiology and treatment of primary brain tumors.
Fernandez AP; Serrano J; Amorim MA; Pozo-Rodrigalvarez A; Martinez-Murillo R
CNS Neurol Disord Drug Targets; 2011 Nov; 10(7):820-33. PubMed ID: 21999731
[TBL] [Abstract][Full Text] [Related]
7. Increased brain tumor microvessel permeability after intracarotid bradykinin infusion is mediated by nitric oxide.
Nakano S; Matsukado K; Black KL
Cancer Res; 1996 Sep; 56(17):4027-31. PubMed ID: 8752174
[TBL] [Abstract][Full Text] [Related]
8. Autocrine factors that sustain glioma invasion and paracrine biology in the brain microenvironment.
Hoelzinger DB; Demuth T; Berens ME
J Natl Cancer Inst; 2007 Nov; 99(21):1583-93. PubMed ID: 17971532
[TBL] [Abstract][Full Text] [Related]
9. Ccl5 establishes an autocrine high-grade glioma growth regulatory circuit critical for mesenchymal glioblastoma survival.
Pan Y; Smithson LJ; Ma Y; Hambardzumyan D; Gutmann DH
Oncotarget; 2017 May; 8(20):32977-32989. PubMed ID: 28380429
[TBL] [Abstract][Full Text] [Related]
10. Targeting nitric oxide and NMDA receptor-associated pathways in treatment of high grade glial tumors. Hypotheses for nitro-memantine and nitrones.
Altinoz MA; Elmaci İ
Nitric Oxide; 2018 Sep; 79():68-83. PubMed ID: 29030124
[TBL] [Abstract][Full Text] [Related]
11. Nitric oxide synthase expression and enzymatic activity in human brain tumors.
Broholm H; Rubin I; Kruse A; Braendstrup O; Schmidt K; Skriver EB; Lauritzen M
Clin Neuropathol; 2003; 22(6):273-81. PubMed ID: 14672505
[TBL] [Abstract][Full Text] [Related]
12. Malignant glioma progression and nitric oxide.
Lam-Himlin D; Espey MG; Perry G; Smith MA; Castellani RJ
Neurochem Int; 2006 Dec; 49(8):764-8. PubMed ID: 16971023
[TBL] [Abstract][Full Text] [Related]
13. Involvement of NOS2 Activity on Human Glioma Cell Growth, Clonogenic Potential, and Neurosphere Generation.
Palumbo P; Lombardi F; Siragusa G; Dehcordi SR; Luzzi S; Cimini A; Cifone MG; Cinque B
Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30227679
[TBL] [Abstract][Full Text] [Related]
14. The potential roles of aquaporin 4 in malignant gliomas.
Lan YL; Wang X; Lou JC; Ma XC; Zhang B
Oncotarget; 2017 May; 8(19):32345-32355. PubMed ID: 28423683
[TBL] [Abstract][Full Text] [Related]
15. NO
Wang J; Hussain SP
Antioxid Redox Signal; 2017 Jun; 26(17):1000-1008. PubMed ID: 27510096
[TBL] [Abstract][Full Text] [Related]
16. Nitric Oxide Synthase and Cyclooxygenase Pathways: A Complex Interplay in Cellular Signaling.
Sorokin A
Curr Med Chem; 2016; 23(24):2559-2578. PubMed ID: 27480213
[TBL] [Abstract][Full Text] [Related]
17. Hypoxia helps glioma to fight therapy.
Amberger-Murphy V
Curr Cancer Drug Targets; 2009 May; 9(3):381-90. PubMed ID: 19442057
[TBL] [Abstract][Full Text] [Related]
18. Sunitinib impedes brain tumor progression and reduces tumor-induced neurodegeneration in the microenvironment.
Hatipoglu G; Hock SW; Weiss R; Fan Z; Sehm T; Ghoochani A; Buchfelder M; Savaskan NE; Eyüpoglu IY
Cancer Sci; 2015 Feb; 106(2):160-70. PubMed ID: 25458015
[TBL] [Abstract][Full Text] [Related]
19. Pathway analysis of glutamate-mediated, calcium-related signaling in glioma progression.
Pei Z; Lee KC; Khan A; Erisnor G; Wang HY
Biochem Pharmacol; 2020 Jun; 176():113814. PubMed ID: 31954716
[TBL] [Abstract][Full Text] [Related]
20. Growth inhibition and chemosensitization of exogenous nitric oxide released from NONOates in glioma cells in vitro.
Weyerbrock A; Baumer B; Papazoglou A
J Neurosurg; 2009 Jan; 110(1):128-36. PubMed ID: 18991497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
